Teamwork Financial Advisors LLC Has $299,000 Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Teamwork Financial Advisors LLC cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 10.6% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 571 shares of the healthcare conglomerate’s stock after selling 68 shares during the period. Teamwork Financial Advisors LLC’s holdings in UnitedHealth Group were worth $299,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of the business. NewSquare Capital LLC bought a new position in UnitedHealth Group during the 4th quarter worth approximately $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new position in UnitedHealth Group in the 4th quarter worth $26,000. Hurley Capital LLC bought a new position in UnitedHealth Group during the 4th quarter worth about $28,000. Aster Capital Management DIFC Ltd bought a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $30,000. Finally, Promus Capital LLC bought a new position in shares of UnitedHealth Group during the fourth quarter worth about $32,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn purchased 1,533 shares of the business’s stock in a transaction dated Wednesday, May 14th. The stock was bought at an average price of $320.80 per share, with a total value of $491,786.40. Following the acquisition, the director now owns 6,033 shares in the company, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Kristen Gil bought 3,700 shares of UnitedHealth Group stock in a transaction on Thursday, May 15th. The stock was acquired at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the acquisition, the director now owns 3,818 shares in the company, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired a total of 109,408 shares of company stock worth $31,607,768 in the last quarter. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Trading Down 1.1%

Shares of UNH stock opened at $301.43 on Wednesday. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73. The firm has a 50 day moving average price of $422.31 and a two-hundred day moving average price of $489.42. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $273.44 billion, a PE ratio of 19.45, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter in the previous year, the business earned $6.91 EPS. As a group, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research firms have weighed in on UNH. Wells Fargo & Company reduced their price target on UnitedHealth Group from $677.00 to $351.00 and set an “overweight” rating for the company in a research report on Wednesday, May 14th. Raymond James downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research report on Wednesday, May 14th. Bank of America cut shares of UnitedHealth Group from a “buy” rating to a “neutral” rating and cut their price target for the stock from $560.00 to $350.00 in a research report on Wednesday, May 14th. Piper Sandler dropped their target price on UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating on the stock in a report on Tuesday. Finally, Robert W. Baird decreased their price target on UnitedHealth Group from $510.00 to $356.00 and set an “outperform” rating for the company in a research note on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and seventeen have assigned a buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $428.43.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.